Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Gout
NCT05324423Phase 1Unknown
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of xininurad in gout, sponsored by The Affiliated Hospital of Qingdao University. Primary endpoints: Observed maximum concentration at steady state at 100 days and Observed area under the concentration-time curve at steady state at 100 days. Status: unknown.
02
Drugs
xininurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT05324423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324423.